[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369773-105":59,"doc-detail-369773-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","up-regulation-of-blood-circulating-tim-4-expressing-monocytes-and-potential-diagnostic-biomarkers","Up-regulation of blood-circulating TIM-4-expressing monocytes and potential diagnostic biomarkers","","Primary hepatocellular carcinoma remains a major global malignancy where early diagnosis is critical. This study examines TIM-4/TIMD4 expression in primary liver cancer tissues and peripheral blood monocytes, and evaluates clinical relevance of soluble TIM-4 (sTIM-4). Immunohistochemistry and bioinformatics show reduced TIM-4 in tumor tissues linked to immune infiltration. Flow cytometry reveals increased TIM-4 in circulating monocytes, mainly the intermediate subset. sTIM-4 and monocyte TIM-4 correlate with liver injury markers and AFP, and sTIM-4 is higher in hepatitis history. ROC analysis indicates combined sTIM-4 and AFP improves diagnostic accuracy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/up-regulation-of-blood-circulating-tim-4-expressing-monocytes-and-potential-diagnostic-biomarkers/369773/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/up-regulation-of-blood-circulating-tim-4-expressing-monocytes-and-potential-diagnostic-biomarkers/369773.png","ImageObject",300,407,{"name":92,"@type":93},"Mabel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What did the study find about TIM-4 expression in primary hepatocellular carcinoma tissues?","Question",{"text":112,"@type":113},"TIM-4 expression was reduced in PHC tissues, and this reduction correlated with immune cell infiltration.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does TIM-4 expression in circulating monocytes differ between PHC patients and controls?",{"text":117,"@type":113},"Flow cytometry showed elevated TIM-4 expression in blood-circulating monocytes of PHC patients, mainly in the intermediate subset.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is sTIM-4 clinically relevant for diagnosing PHC?",{"text":121,"@type":113},"sTIM-4 levels correlated positively with AFP and liver injury markers, were higher in patients with hepatitis history, and combining sTIM-4 with AFP improved diagnostic accuracy in ROC analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369773,1790215720,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nUp-regulation of blood-circulating TIM-4-expressing monocytes and potential diagnostic biomarkersTIM-4 in primary liver cancer  \nYifeng Yang1,8, Yan Wei2,8, Yilian Zhao3,8, Chao Ye4, Dan Zeng5, Xiaoxing Zhou4, Mengru Xie3, Xingcai Chen1, Jilin Qing6􀀍 & Zhizhong Chen7􀀍  \nPrimary hepatocellular carcinoma (PHC) remains a globally prevalent malignancy, where early diagnosis is critical. Monocytes have been implicated in tumor progression. This study investigated the expression ofT cell immunoglobulin and mucin domain-containing protein 4 (TIM-4/TIMD4) in PHC tissues and peripheral blood monocytes, and assessed the clinical relevance of soluble TIM-4 (sTIM-4). Immunohistochemistry and bioinformatics analyses revealed reduced TIM-4 expression in PHC tissues, which correlated with immune cell infiltration. Flow cytometry showed elevated TIM-4 expression in circulating monocytes of PHC patients, predominantly within the intermediate subset (91.7%). sTIM-4 and monocyte TIM-4 levels were positively correlated with alpha-fetoprotein (AFP), alanine aminotransferase (ALT), aspartate aminotransferase(AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), and negatively correlated with albumin (ALB) . Notably, sTIM-4 levels were significantly higher in patients with a history of hepatitis. Logistic regression indicated that elevated sTIM-4 was associated with a 2.29-fold increased risk of PHC. ROC analysis demonstrated that the combination of sTIM-4 and AFP improved diagnostic accuracy for PHC. In conclusion, TIM-4 is downregulated in PHC tissues but upregulated in circulating intermediate monocytes, suggesting its dual role in tumor immunobiology. The combined measurement ofsTIM-4 and AFP enhances diagnostic sensitivity and offers predictive value for PHC risk stratification.  \nKeywords Primary liver cancer, TIM-4, sTIM-4, Blood-circulating monocyte subsets  \nLiver cancer is among the most prevalent malignant tumors worldwide. In 2020, an estimated 90.6 million individuals were diagnosed with the disease1,2, making it the third leading cause of cancer-related deaths globally, with a relative five-year survival rate of approximately 18%1. The high incidence and mortality underscore its poor prognosis. Liver cancer can be classified into primary liver cancer (PHC)—characterized by aggressive biological behavior—and secondary liver cancer3. Hepatocellular carcinoma (HCC, also referred to as LIHC) accounts for 80–90% of PHC cases, while intrahepatic cholangiocarcinoma contributes to 10–15%4. Most PHC patients have underlying chronic liver conditions, commonly due to hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, with HBV predominating in Asia5.  \nThe slow pace of advancements in prevention and early detection has contributed to the rising incidence of PHC. Currently, the sensitivity of abdominal ultrasonography for early PHC detection remains suboptimal, especially in patients with obesity or non-viral liver disease6. While blood-based monitoring strategies show promise, they still require further validation before clinical practice6. In recent years, immune checkpoint inhibitor (ICI)-based therapies have become widely used for advanced PHC treatment7. Although ICIs,  \n1Laboratory Department, People’s Hospital of Guilin, Guilin 541000, China. 2Graduate College, Guangxi University of Chinese Medicine, Nanning 530200, China. 3Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning 530021, China. 4Clinical Medical College, Guilin Medical University, Guilin 541000, China.  \n5Genetics and Precision Medicine Laboratory, Affiliated Hospital of Guilin Medical University, Guilin 541000, China. 6Reproductive Medicine Center, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530000, China. 7Joint Inspection ","cbCainC6TTreJ2Qj","https://ap.wps.com/l/cbCainC6TTreJ2Qj","pdf",11709433,15,"English","# Background\n## Liver cancer burden and current diagnostic challenges\n## Role of immune therapies and need for novel targets\n\n# TIM-4 biology and rationale\n## TIM family overview and TIM-4 functions\n## Prior findings in other diseases\n\n# Study design and methods\n## Expression assessment in tissues and monocytes\n## Soluble TIM-4 evaluation and clinical correlations\n\n# Results\n## TIM-4 expression differences in tissues versus circulating monocytes\n## Correlations with laboratory indicators and hepatitis history\n## Risk association and ROC diagnostic performance\n\n# Conclusion\n## Dual role of TIM-4 and combined biomarkers for PHC diagnosis","[{\"question\":\"What did the study find about TIM-4 expression in primary hepatocellular carcinoma tissues?\",\"answer\":\"TIM-4 expression was reduced in PHC tissues, and this reduction correlated with immune cell infiltration.\"},{\"question\":\"How does TIM-4 expression in circulating monocytes differ between PHC patients and controls?\",\"answer\":\"Flow cytometry showed elevated TIM-4 expression in blood-circulating monocytes of PHC patients, mainly in the intermediate subset.\"},{\"question\":\"Why is sTIM-4 clinically relevant for diagnosing PHC?\",\"answer\":\"sTIM-4 levels correlated positively with AFP and liver injury markers, were higher in patients with hepatitis history, and combining sTIM-4 with AFP improved diagnostic accuracy in ROC analysis.\"}]","Up-regulation of blood-circulating TIM-4-expressing monocytes and potential diagnostic biomarkers | PDF",1790184483,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21a3faa14f1f4ac596ccbb7097d34fe3.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b64e101d854f8cd66156efbea926f9bf.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a34082405863237fc83d887b2a6701b2.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a80e909e74afa7fbf2790cf2cf3e1931.webp",980,1287]